A detailed history of Stableford Capital Ii LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Stableford Capital Ii LLC holds 15,677 shares of JNJ stock, worth $2.29 Million. This represents 1.0% of its overall portfolio holdings.

Number of Shares
15,677
Previous 14,896 5.24%
Holding current value
$2.29 Million
Previous $2.33 Million 6.21%
% of portfolio
1.0%
Previous 1.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 09, 2024

BUY
$155.22 - $162.74 $121,226 - $127,099
781 Added 5.24%
15,677 $2.48 Million
Q4 2023

Jan 12, 2024

BUY
$145.6 - $158.88 $41,350 - $45,121
284 Added 1.94%
14,896 $2.33 Million
Q3 2023

Oct 30, 2023

BUY
$155.75 - $174.48 $92,827 - $103,990
596 Added 4.25%
14,612 $2.28 Million
Q2 2023

Aug 11, 2023

BUY
$154.35 - $166.11 $2.16 Million - $2.33 Million
14,016 New
14,016 $2.32 Million
Q4 2022

Jan 10, 2023

SELL
$160.2 - $179.79 $12,175 - $13,664
-76 Reduced 1.29%
5,793 $1.02 Billion
Q3 2022

Oct 25, 2022

BUY
$161.33 - $179.52 $9,034 - $10,053
56 Added 0.96%
5,869 $990,000
Q2 2022

Oct 25, 2022

SELL
$168.19 - $186.01 $9,418 - $10,416
-56 Reduced 0.95%
5,813 $995,000
Q2 2022

Aug 08, 2022

SELL
$168.19 - $186.01 $63,071 - $69,753
-375 Reduced 6.06%
5,813 $995,000
Q1 2022

Apr 11, 2022

SELL
$158.14 - $179.59 $76,223 - $86,562
-482 Reduced 7.23%
6,188 $1.13 Million
Q4 2021

Jan 28, 2022

BUY
$155.93 - $173.01 $154,838 - $171,798
993 Added 17.49%
6,670 $1.09 Million
Q3 2021

Oct 18, 2021

SELL
$161.5 - $179.47 $18,572 - $20,639
-115 Reduced 1.99%
5,677 $909,000
Q2 2021

Aug 06, 2021

BUY
$159.48 - $171.07 $26,314 - $28,226
165 Added 2.93%
5,792 $954,000
Q1 2021

May 03, 2021

SELL
$153.07 - $170.48 $10,867 - $12,104
-71 Reduced 1.25%
5,627 $925,000
Q4 2020

Feb 02, 2021

BUY
$137.11 - $157.38 $575,999 - $661,153
4,201 Added 280.63%
5,698 $897,000
Q2 2020

Feb 10, 2021

BUY
$128.81 - $155.51 $192,828 - $232,798
1,497 New
1,497 $211,000
Q1 2020

Feb 10, 2021

SELL
$111.14 - $153.99 $435,668 - $603,640
-3,920 Closed
0 $0
Q4 2019

Feb 10, 2021

SELL
$127.5 - $146.44 $765 - $878
-6 Reduced 0.15%
3,920 $572,000
Q3 2019

Feb 10, 2021

BUY
$126.95 - $142.14 $22,851 - $25,585
180 Added 4.81%
3,926 $508,000
Q2 2019

Feb 10, 2021

SELL
$131.15 - $144.24 $45,509 - $50,051
-347 Reduced 8.48%
3,746 $522,000
Q1 2019

Feb 10, 2021

SELL
$125.72 - $139.79 $139,674 - $155,306
-1,111 Reduced 21.35%
4,093 $572,000
Q4 2018

Feb 12, 2021

SELL
$122.84 - $147.84 $79,477 - $95,652
-647 Reduced 11.06%
5,204 $672,000
Q3 2018

Feb 10, 2021

SELL
$121.58 - $142.88 $66,017 - $77,583
-543 Reduced 8.49%
5,851 $808,000
Q2 2018

Feb 10, 2021

BUY
$119.4 - $131.76 $32,476 - $35,838
272 Added 4.44%
6,394 $776,000
Q1 2018

Feb 10, 2021

BUY
$125.1 - $148.14 $29,648 - $35,109
237 Added 4.03%
6,122 $785,000
Q4 2017

Feb 10, 2021

BUY
$131.22 - $143.62 $30,180 - $33,032
230 Added 4.07%
5,885 $822,000
Q3 2017

Feb 10, 2021

BUY
$129.47 - $135.38 $103,446 - $108,168
799 Added 16.45%
5,655 $735,000
Q2 2017

Feb 11, 2021

SELL
N/A
-799 Reduced 14.13%
4,856 $642,000
Q2 2017

Feb 10, 2021

BUY
N/A
1,547 Added 37.66%
5,655 $735,000
Q1 2017

Feb 10, 2021

BUY
N/A
2,207 Added 116.1%
4,108 $512,000
Q4 2016

Feb 10, 2021

BUY
N/A
1,901
1,901 $219,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $382B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Stableford Capital Ii LLC Portfolio

Follow Stableford Capital Ii LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stableford Capital Ii LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stableford Capital Ii LLC with notifications on news.